Evaluate the effectiveness of adding lutropin alfa (recombinant human luteinizing hormone
[r-hLH]) in the middle of the follicular phase compared to no addition, in infertile women at
risk of poor response stimulated with follitropin alfa (recombinant Follicle-Stimulating
Hormone [r-FSH]) under Gonadotropin Releasing Hormone (GnRH) antagonist in vitro
fertilization (IVF)/intracytoplasmic sperm injection (ICSI), in the number and quality of
oocytes, follicular development, fertilization oocyte, embryo quality, and pregnancy rate.